Corbus Pharmaceuticals Holdings, Inc.
CRBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $17 | $14 | $17 | $25 |
| Short-Term Investments | $132 | $7 | $42 | $73 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $3 | $1 | $3 |
| Total Curr. Assets | $153 | $24 | $60 | $100 |
| Property Plant & Equip (Net) | $3 | $4 | $5 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $1 | $1 |
| Total NC Assets | $3 | $5 | $6 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $156 | $28 | $66 | $108 |
| Liabilities | – | – | – | – |
| Payables | $5 | $3 | $2 | $2 |
| Short-Term Debt | $2 | $18 | $4 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $11 | $6 | $10 |
| Total Curr. Liab. | $12 | $32 | $13 | $17 |
| LT Debt | $2 | $3 | $21 | $22 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $3 | $21 | $22 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $5 | $6 | $7 |
| Total Liabilities | $13 | $35 | $33 | $39 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$477 | -$437 | -$392 | -$350 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $619 | $430 | $425 | $419 |
| Total Equity | $142 | -$7 | $33 | $69 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $156 | $28 | $66 | $108 |
| Net Debt | -$14 | $7 | $8 | $2 |